Results 51 to 60 of about 36,401 (249)
ABSTRACT Aim Timeline of atherosclerosis in children with type 1 diabetes is unknown. We aimed to investigate if familial risk of type 1 diabetes is associated with pro‐atherosclerotic changes. Methods Young first‐degree relatives to patients with paediatric type 1 diabetes and sex and age matching controls were enrolled at Skåne University Hospital ...
Josefin Holmgren+6 more
wiley +1 more source
Pediatric non-diabetic ketoacidosis: a case-series report
Background This study is to explore the clinical characteristics, laboratory diagnosis, and treatment outcomes in pediatric patients with non-diabetic ketoacidosis. Methods Retrospective patient chart review was performed between March 2009 to March 2015.
Ke Bai+4 more
doaj +1 more source
Treatment options for immune‐related adverse events associated with immune checkpoint inhibitors
Abstract The immunotherapy revolution with the use of immune checkpoint inhibitors (ICIs) started with the clinical use of the first ICI, ipilimumab, in 2011. Since then, the field of ICI therapy has rapidly expanded — with the FDA approval of 10 different ICI drugs so far and their incorporation into the therapeutic regimens of a range of malignancies.
Yu Hua Chen+3 more
wiley +1 more source
ABSTRACT This paper explores lights and landscapes as depicted in near‐death experiences (NDEs). NDEs are specific experiences, which human beings with a (perceived) close brush with death may have and later recall, often including seeing a brilliant light and sometimes traveling to unearthly dimensions, which may or may not include landscapes.
Tobias Anker Stripp
wiley +1 more source
Objective: To assess the incidence of diabetic ketoacidosis in coronavirus disease-2019 patients and their survival rate, and to compare their outcomes with diabetic ketoacidosis patients without coronavirus disease-2019.
Asma Ahmed+4 more
doaj +1 more source
Abstract Aims The MiniMed™ 780G improves glycaemia and reduces burden in type 1 diabetes. We investigated how new all‐in‐one “Simplera Sync™” sensors and 7‐day Extended™ Wear Infusion Sets (EIS) affect glycaemia and system performance in young people with previously elevated HbA1c levels (≥69 mmol/mol [≥8%]) after transitioning from 780G with Guardian ...
Venus R. Michaels+8 more
wiley +1 more source
Abstract Aims Following an acute myocardial infarction (AMI), individuals with type 2 diabetes (T2DM) have a 2‐to‐3 fold increased risk of mortality compared to those without diabetes, and globally cardiorenal complications account for 50% of diabetes‐related deaths.
M. U. Shah+4 more
wiley +1 more source
Abstract Aims To compare variable‐rate intravenous insulin infusion (VRIII) to fixed‐rate intravenous insulin infusion (FRIII) on the incidence of hypoglycaemia during DKA management. Secondary outcomes were time to resolution of ketosis and hospital length of stay.
Stephanie Baddock+4 more
wiley +1 more source
Fikaden Berhe Hadgu,1 Gereziher Gebremedhin Sibhat,2 Letekirstos GebreEgziabher Gebretsadik31Department of Pediatrics and Child Health, College of Health Sciences, Mekelle University, Tigray, Ethiopia; 2Department of Pharmacognocy, School of Pharmacy ...
Hadgu FB, Sibhat GG, Gebretsadik LG
doaj
Diabetic ketoacidosis is a feared complication in patients with diabetes mellitus and poses high risk of mortality and morbidity unless treated in timely manner.
Sana Idrees+4 more
doaj +1 more source